Monocentric, open-label, phase III study that compares the efficiency and tolerance between intravesical oxybutynin and oral fesoterodine in children (5-16y) with neurogenic detrusor overactivity.
Phase of Trial: Phase III
Latest Information Update: 22 Aug 2014
At a glance
- Drugs Fesoterodine (Primary) ; Oxybutynin; Tolterodine
- Indications Detrusor instability
- Focus Therapeutic Use
- 22 Aug 2014 New trial record